SYNBIO.INTEL
DNAGinkgo+PlatformTWSTTwist+SynthesisABSIAbsci+AIDesignCRSPCRISPR Therapeutics+EditBEAMBeam+BaseEditNTLAIntellia+InVivoCRBUCaribou+CellTherapyRXRXRecursion+AIILMNIllumina+SeqEDITEditas+GeneFUND.YTD2025$17.3B.Raised
Terminal/Companies/Zymergen (acquired by Ginkgo)
acquiredFounded 2013

Zymergen (acquired by Ginkgo)

HQ: Emeryville, CA, USA (formerly)CEO: N/A (acquired)Headcount: N/A
Funding Summary
Total Funding
$1B+
Latest Valuation
~$300M (acquisition price, 2022)
About

Combined AI, automation, and biology for specialty materials. After IPO at $3B+, abandoned lead product and was acquired by Ginkgo for ~$300M.

platform Programs
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →